According to the current analysis of Reports and Data, the Hemostats Market was valued at USD 2,409.4 Million in 2020 and is expected to reach USD 3,862.9 Million by the year 2028, at a CAGR of 6.2%. It is a surgical instrument that is used to control the flow of blood during surgical procedures. These surgical hemostats are used in the initial steps of surgery when an incision is performed. It can be used in various forms like sealants, topical hemostats, and mechanical instruments, which are meant for surgical use only. The major goal of a hemostat is the adhesion of wounds, to cease blood flow, and ensure rapid healing of the wound. The hemostat market is widely driven by the free fall in lifestyle due to which lifestyle-oriented diseases occur in many people. Various diseases, especially cardiovascular and orthopedic diseases, are treated through surgical procedures, which is extensively driving the market.

The number of reconstructive procedures, significantly tumor removal, has constantly been increasing. According to the American Society of Plastic Surgeons (ASPS), approximately 4.5 million tumor removal procedures were performed in 2020 in the US. The obesity epidemic is also increasing in the US, fueling the market. An annual report from the United Health Foundation stated that there had been a significant increase in the obesity rate of the U.S. by 5%. The obesity rate was recorded to be 29.9% in 2017, which increased to 31.3% in 2020. The geriatric population require critical care and are quite acquainted with surgical procedures. This population is widely affected by orthopedic surgeries due to a decrease in bone density. Therefore, the elderly population is widely driving the market.

The new technological advancements have led the market to grow. Many companies such as Baxter, Ethicon (JJ), and others have invested in research and development for new innovative products of hemostats, making it effortless to use for the end users. These devices are economical and cost efficient, therefore anticipating market growth.

Some of the market restraints include low awareness about hemostats and their use. Also, stringent rules are devised by the regulating bodies to use hemostats to avoid any kind of infections or allergies after use. 

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2516

The key player in the market includes Johnson and Johnson, Baxter International, Pfizer, Integra Life Sciences, Z-Medica LLC, Abbott Laboratories, B. Braun Melsungen AG, CR Bard, Gelita Medical GmbH and Hemostasis LLC.

Further key findings from the report suggest

• North America is the leading consumer of the hemostats, further followed by the Asia-Pacific and Europe. Asia-Pacific is the fastest growing region with a CAGR of 7.0%. The increasing number of surgeries and changes in regulatory policies encourages the market in the region.
• A wide range of applications, continuous advancement in the product portfolio of companies such as Ethicon and Baxter international have widely driven the market. The products from these key players have received approval from the U.S. FDA as well as by other international organizations.
• Recently, in December 2020, Baxter introduced a surgical innovation, which, a disposable curved applicator which enhances the activity of Floseal. Floseal is a hemostat product by Baxter used for ENT procedures. This advancement has improved the efficacy of Floseal and made it the leading hemostat in the US.
• Recently, in May 2019, the FDA might loosen up the premarket expectations of certain collagen-based hemostats and shift them to class-II devices rather than class III devices. The recommendation was given by the general and plastic surgery devices panel. Ethicon (JJ) is against this recommendation stating that collagen-based hemostats are complex products and need strict controls to ensure safety.

To know more about the report @ https://www.reportsanddata.com/report-detail/hemostat-market

For the purpose of this report, Reports and Data has segmented the Hemostat market on the basis of product, application, formulation and region:

Product Outlook (Revenue in Million USD; 2018–2028)

• Thrombin-based hemostats
• Gelatin-based hemostats
• Collagen-based hemostats
• Combination hemostats
• Oxidized regenerated cellulose-based hemostats

Application Outlook (Revenue in Million USD; 2018–2028)

• General surgery
• Orthopedic surgery
• Cardiovascular surgery
• Reconstructive surgery
• Gynecological surgery
• Neurological surgery
• Other surgeries

Formulation Outlook (Revenue in Million USD; 2018–2028)

• Sheet pad hemostat
• Sponge hemostats
• Matrix gel hemostats
• Powder hemostat

End Use Outlook (Revenue in Million USD; 2018–2028)

• Hospitals
• Clinics
• Ambulatory centers
• Community healthcare
• Others

Regional Outlook:

• North America
  • S.
  • Canada
  • Mexico
• Europe
  • Germany
  • K.
  • Italy
  • France
  • BENELUX
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of APAC
• Latin America
  • Brazil
  • Rest of LATAM
• Middle East Africa
  • Saudi Arabia
  • A.E.
  • South Africa
  • Rest of MEA

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2516

Thank you for reading our report. Get in touch with us to know more about the customization feature and our team with provide you the best suited report as per your need.

About Us:

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyse consumer behaviour shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Power and Energy, and Chemicals. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

Read Our Innovative Blogs @ https://www.reportsanddata.com/blogs

Read Full Press Release: https://www.reportsanddata.com/press-release/global-hemostat-market